Genetic testing would represent one mechanism for identifying those people who are at risk of developing DLB, since the presence of a GBA1 mutation has been identified as a clear risk factor for DLB [14,15], yet most patients do not carry this mutation [16,17]. Here, GBA1 is linked to Lewy body dementia.